Skip to main content
. 2022 Apr 12;14(4):845. doi: 10.3390/pharmaceutics14040845

Figure 5.

Figure 5

MC3T3-E1 cell proliferation after 1 and 3 d of exposure to (A) 200 µg/mL and (B) 300 µg/mL of HBGN. Significant differences with respect to control cells (absence of HBGN) are marked with an asterisk. Significance p < 0.05.